Becton Dickinson
Becton Dickinson was founded in 1897 and is headquartered in Franklin Lakes, US
Report incorrect company information
Key People/Management at Becton Dickinson
Vincent Forlenza
Chairman of the Board, Chief Executive Officer and President
Gary Cohen
Executive Vice President and President, Global Health
James Lim
Executive Vice President and President, Greater Asia
Christopher Reidy
Executive Vice President, Chief Financial Officer and Chief Administrative Officer
Report incorrect company information
Becton Dickinson Office Locations
Becton Dickinson has offices in Four Oaks, Franklin, St Paul, Zachary and in 93 other locations
Franklin Lakes, US (HQ)
Howe Buidling 1 Becton Dr
San Jose, US
2150 Commerce Dr
Report incorrect company information
Becton Dickinson Financials and Metrics
Becton Dickinson Financials
Becton Dickinson's revenue was reported to be $12.09 b in FY, 2017
| USD | |
|---|---|
Revenue (Q2, 2018) | 7.3 b |
Gross profit (Q2, 2018) | 3.2 b |
Gross profit margin (Q2, 2018), % | 43.2% |
Net income (Q2, 2018) | (148 m) |
EBIT (Q2, 2018) | 413 m |
Market capitalization (22-Jun-2018) | 63.5 b |
Closing share price (22-Jun-2018) | 237.6 |
Cash (31-Mar-2018) | 1.3 b |
EV | 84.8 b |
Becton Dickinson's current market capitalization is $63.5 b.
- Source: SEC Filings
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2 b | 2.1 b | 2.2 b | 2.1 b | 2.1 b | 3.1 b | 3 b | 3.1 b | 3.2 b | 2.9 b | 3 b | 3 b | 7.3 b |
Cost of goods sold | 980 m | 1 b | 1 b | 1 b | 1 b | 1.9 b | 1.6 b | 1.6 b | 1.7 b | 1.5 b | 1.5 b | 1.5 b | 4.1 b |
Gross profit | 1 b | 1.1 b | 1.1 b | 1 b | 1 b | 1.2 b | 1.4 b | 1.5 b | 1.5 b | 1.5 b | 1.4 b | 1.5 b | 3.2 b |
Gross profit Margin, % | 51% | 51% | 52% | 51% | 51% | 38% | 47% | 48% | 48% | 50% | 48% | 50% | 43% |
- Source: SEC Filings
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 1.7 b | 1.7 b | 1.7 b | 8.5 b | 1.9 b | 1.6 b | 1.6 b | 1.7 b | 1.7 b | 919 m | 548 m | 13.9 b | 1.3 b |
Accounts Receivable | 1.1 b | 1.1 b | 1.2 b | 1 b | 1.6 b | 1.6 b | 1.5 b | 1.6 b | 1.6 b | 1.5 b | 1.6 b | 1.7 b | 2.3 b |
Inventories | 1.5 b | 1.5 b | 1.6 b | 1.5 b | 2.3 b | 2 b | 2 b | 1.8 b | 1.8 b | 1.7 b | 1.7 b | 1.8 b | 2.5 b |
Current Assets | 5.7 b | 5.9 b | 6 b | 12.1 b | 7 b | 6.3 b | 5.6 b | 6.6 b | 6.5 b | 5.2 b | 4.9 b | 18.2 b | 7.5 b |
Annual
| USD | Y, 2018 |
|---|---|
EV/EBIT | 205.4 x |
EV/CFO | 83.4 x |
EV/FCF | 135.5 x |
Financial Leverage | 2.6 x |
Becton Dickinson Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| Sirigen Inc | August 27, 2012 | |
| Carmel Pharma Inc | July 11, 2011 | |
| Accuri Cytometers | March 11, 2011 | |
| HandyLab Inc | November 20, 2009 | $275 m |
| Cytopeia | August 23, 2008 | |
| GeneOhm Sciences | January 10, 2006 | |
| Atto Bioscience | July 01, 2004 | $25 m |
| Difco | June 02, 1997 | |
| Plasso Technology Limited | ||
| PreAnalytiX |
Becton Dickinson Revenue Breakdown
Becton Dickinson revenue breakdown by business segment: 30.7% from Life Sciences and 69.3% from Medical
Report incorrect company information
Becton Dickinson Online and Social Media Presence
Report incorrect company information